Skip to main content
Fig. 9 | European Journal of Medical Research

Fig. 9

From: Predicting the prognosis, immune response, and immunotherapy in head and neck squamous cell carcinoma using a novel risk model based on anoikis-related lncRNAs

Fig. 9

Impact of anoikis-related lncRNA signature on immunotherapy response. Correlation of the anoikis-related lncRNA signature and IPS for A anti-PD1 immunotherapy, B anti CTLA4 monotherapy and C combined anti-PD1 with anti-CTLA4 immunotherapy. D Comparison of the immune-linked gene expression levels between the two risk groups

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us